Prosecution Insights
Prosecution Insights
8 pending office actions • 5 art units • 7 examiners • 0 of 8 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 6 (75%) |
| §112 only | 1 (12%) |
| No statute on record | 1 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HILL, KEVIN KAI | 2 | 36.2% | +33.4% |
| FRITH, SEAN A | 1 | 61.2% | +27.6% |
| PUTTLITZ, KARL J | 1 | 69.1% | +18.4% |
| PATTERSON, SARAH COOPER | 1 | 58.6% | +56.4% |
| MIDDLETON, DANAYA L | 1 | 43.5% | +53.4% |
| O'BRIEN, LEA S | 1 | 50.0% | +8.3% |
| SANG, HONG | 1 | 54.7% | +61.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17056749 | IMPROVED CELL THERAPY COMPOSITIONS FOR HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS | HILL, KEVIN KAI | 44d overdue |
| 17331296 | GENERATING VIRUS OR OTHER ANTIGEN-SPECIFIC T CELLS FROM A NAÏVE T CELL POPULATION | SANG, HONG | 31d overdue |
| 19108200 | RHEUMATIC HEART DISEASE DETECTION FROM ECHOCARDIOGRAMS | FRITH, SEAN A | 16d overdue |
| 18008422 | USE OF RECOMBINANT HUMAN ACID SPHINGOMYELINASE TO IMPROVE SKELETAL MYOFIBER REPAIR | HILL, KEVIN KAI | 28d |
| 17425130 | WHOLE CELL TUMOR VACCINES AND METHODS OF USE THEROF | MIDDLETON, DANAYA L | 28d |
| 17926188 | IDENTIFICATION OF HLA-RESTRICTED PRAME PEPTIDE EPITOPES, PRAME-SPECIFIC T CELLS SUITABLE FOR "OFF-THE-SHELF" TREATMENT OF CANCER EXPRESSING PRAME | PUTTLITZ, KARL J | 33d |
| 17537816 | CYTOKINE COCKTAILS FOR SELECTIVE EXPANSION OF T CELL SUBSETS | PATTERSON, SARAH COOPER | 70d |
| Art Unit | Apps |
|---|---|
| 1646 | 3 |
| 1638 | 2 |
| 3798 | 1 |
| 1675 | 1 |
| 1674 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19108200 | RHEUMATIC HEART DISEASE DETECTION FROM ECHOCARDIOGRAMS | FRITH, SEAN A | 3798 | §103 | Non-Final OA | 16d overdue | Pending | Mar 03, 2025 |
| 18008422 | USE OF RECOMBINANT HUMAN ACID SPHINGOMYELINASE TO IMPROVE SKELETAL MYOFIBER REPAIR | HILL, KEVIN KAI | 1638 | §103 | Final Rejection | 28d | Pending | Dec 05, 2022 |
| 17926188 | IDENTIFICATION OF HLA-RESTRICTED PRAME PEPTIDE EPITOPES, PRAME-SPECIFIC T CELLS SUITABLE FOR "OFF-THE-SHELF" TREATMENT OF CANCER EXPRESSING PRAME | PUTTLITZ, KARL J | 1646 | §103 | Final Rejection | 33d | Pending | Nov 18, 2022 |
| 17537816 | CYTOKINE COCKTAILS FOR SELECTIVE EXPANSION OF T CELL SUBSETS | PATTERSON, SARAH COOPER | 1675 | §103 | Non-Final OA | 70d | Pending | Nov 30, 2021 |
| 17425130 | WHOLE CELL TUMOR VACCINES AND METHODS OF USE THEROF | MIDDLETON, DANAYA L | 1674 | §103 | Non-Final OA | 28d | Pending | Jul 22, 2021 |
| 17421337 | EX VIVO ACTIVATED T-LYMPHOCYTIC COMPOSITIONS AND METHODS OF USING THE SAME | O'BRIEN, LEA S | 1646 | Other | Non-Final OA | 26d | Pending | Jul 07, 2021 |
| 17331296 | GENERATING VIRUS OR OTHER ANTIGEN-SPECIFIC T CELLS FROM A NAÏVE T CELL POPULATION | SANG, HONG | 1646 | §112 | Non-Final OA | 31d overdue | Pending | May 26, 2021 |
| 17056749 | IMPROVED CELL THERAPY COMPOSITIONS FOR HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS | HILL, KEVIN KAI | 1638 | §103 | Non-Final OA | 44d overdue | Pending | Nov 18, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial